Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 42.44% is 29% below its 5-year average of 59.59%, near the low end of its 5-year range (0.00%–147.12%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.74% above its 12-month average of 31.97%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 42.44%.
DEBT TO ASSETS RATIO
42.44%
DEBT TO ASSETS RATIO AVG TTM
31.97%
DEBT TO ASSETS RATIO AVG 3Y
77.81%
DEBT TO ASSETS RATIO AVG 5Y
59.59%
DEBT TO ASSETS RATIO AVG 10Y
68.10%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+32.74%
CURRENT VS 3Y AVG
-45.45%
CURRENT VS 5Y AVG
-28.78%
CURRENT VS 10Y AVG
-37.68%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+47058.81%
vs the sector median at left
PAVmed Inc.
Market Cap
$17.43M
Debt to Assets Ratio
42.44%
TTM Avg
31.97%
3Y Avg
77.81%
5Y Avg
59.59%
Market Cap
$17.37M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.99M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.81M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.70M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.70M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.62M
Debt to Assets Ratio
0.53%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PAVmed Inc. (PAVM) | $17.43M | 42.44% | 31.97% | 77.81% | 59.59% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.37M | 0.00% | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.11M | 0.00% | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | 0.00% | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $18.04M | 0.26% | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.81M | 0.03% | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.70M | 0.77% | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.70M | 0.14% | N/A | N/A | N/A |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.62M | 0.53% | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.67M | 0.00% | N/A | N/A | N/A |
Debt/Assets
42.4%
Debt/Equity
0.49
Current Ratio
1.19
Interest Coverage
-1038.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 42.44% |
| 2026-03-31 | 37.45% |
| 2025-12-31 | 34.39% |
| 2025-09-30 | 24.38% |
| 2025-06-30 | 21.21% |
| 2025-03-31 | 17.49% |
| 2024-12-31 | 103.91% |
| 2024-09-30 | 114.33% |
| 2024-06-30 | 126.95% |
| 2024-03-31 | 133.37% |
| 2023-12-31 | 147.12% |
| 2023-09-30 | 118.77% |
| 2023-06-30 | 89.68% |
| 2023-03-31 | 75.82% |
| 2022-12-31 | 67.87% |
| 2022-09-30 | 53.16% |
| 2022-06-30 | 39.57% |
| 2022-03-31 | 3.53% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.58% |
| 2020-12-31 | 75.64% |
| 2020-09-30 | 195.35% |
| 2020-06-30 | 185.77% |
| 2020-03-31 | 204.30% |
| 2019-12-31 | 112.42% |
| 2019-09-30 | 101.49% |
| 2019-06-30 | 96.17% |
| 2019-03-31 | 189.44% |
| 2018-12-31 | 93.02% |
| 2018-09-30 | 34.65% |
| 2018-06-30 | 24.48% |
| 2018-03-31 | 59.86% |
| 2017-12-31 | 118.58% |
| 2017-09-30 | 48.96% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
